Perrigo Gross Profit 2010-2025 | PRGO
Perrigo gross profit from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| Perrigo Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $1,543 |
| 2023 | $1,680 |
| 2022 | $1,455 |
| 2021 | $1,416 |
| 2020 | $1,495 |
| 2019 | $1,434 |
| 2018 | $1,832 |
| 2017 | $1,980 |
| 2016 | $2,052 |
| 2015 | $1,079 |
| 2015 | $1,644 |
| 2014 | $1,452 |
| 2013 | $1,280 |
| 2012 | $1,096 |
| 2011 | $945 |
| 2010 | $746 |
| 2009 | $597 |
| Perrigo Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-03-31 | $392 |
| 2024-12-31 | $386 |
| 2024-09-30 | $404 |
| 2024-06-30 | $395 |
| 2024-03-31 | $358 |
| 2023-12-31 | $427 |
| 2023-09-30 | $411 |
| 2023-06-30 | $428 |
| 2023-03-31 | $414 |
| 2022-12-31 | $383 |
| 2022-09-30 | $363 |
| 2022-06-30 | $372 |
| 2022-03-31 | $338 |
| 2021-12-31 | $362 |
| 2021-09-30 | $336 |
| 2021-06-30 | $349 |
| 2021-03-31 | $368 |
| 2020-12-31 | $384 |
| 2020-09-30 | $370 |
| 2020-06-30 | $347 |
| 2020-03-31 | $394 |
| 2019-12-31 | $141 |
| 2019-09-30 | $413 |
| 2019-06-30 | $431 |
| 2019-03-31 | $449 |
| 2018-12-31 | $443 |
| 2018-09-30 | $425 |
| 2018-06-30 | $471 |
| 2018-03-31 | $493 |
| 2017-12-31 | $513 |
| 2017-09-30 | $498 |
| 2017-06-30 | $505 |
| 2017-03-31 | $464 |
| 2016-12-31 | $488 |
| 2016-09-30 | $485 |
| 2016-06-30 | $547 |
| 2016-03-31 | $533 |
| 2015-12-31 | $-427 |
| 2015-09-30 | $535 |
| 2015-06-30 | |
| 2015-03-31 | $369 |
| 2014-12-31 | $384 |
| 2014-09-30 | $322 |
| 2014-06-30 | |
| 2014-03-31 | $315 |
| 2013-12-31 | $361 |
| 2013-09-30 | $356 |
| 2013-06-30 | |
| 2013-03-31 | $331 |
| 2012-12-31 | $307 |
| 2012-09-30 | $285 |
| 2012-06-30 | |
| 2012-03-31 | $279 |
| 2011-12-31 | $295 |
| 2011-09-30 | $228 |
| 2011-06-30 | |
| 2011-03-31 | $239 |
| 2010-12-31 | $250 |
| 2010-09-30 | $214 |
| 2010-06-30 | |
| 2010-03-31 | $187 |
| 2009-12-31 | $198 |
| 2009-09-30 | $163 |
| 2009-06-30 | |
| 2009-03-31 | $150 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.672B | $4.373B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.390B | 27.94 |
| Boston Scientific (BSX) | United States | $154.114B | 38.58 |
| Stryker (SYK) | United States | $145.370B | 30.40 |
| EssilorLuxottica (ESLOY) | France | $128.999B | 0.00 |
| Medtronic (MDT) | Ireland | $107.400B | 15.23 |
| Haleon (HLN) | United Kingdom | $51.375B | 29.26 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.537B | 0.00 |
| ResMed (RMD) | United States | $35.781B | 26.88 |
| GE HealthCare Technologies (GEHC) | United States | $32.121B | 15.25 |
| Agilent Technologies (A) | United States | $31.661B | 20.57 |
| Terumo (TRUMY) | Japan | $27.316B | 35.48 |
| Insulet (PODD) | United States | $22.872B | 89.78 |
| Koninklijke Philips (PHG) | Netherlands | $21.440B | 15.41 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.026B | 11.58 |
| Baxter (BAX) | United States | $15.164B | 11.32 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.767B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $5.893B | 20.51 |
| Lantheus Holdings (LNTH) | United States | $5.336B | 13.46 |
| Prestige Consumer Healthcare (PBH) | United States | $4.224B | 18.87 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.304B | 15.05 |
| ICU Medical (ICUI) | United States | $3.213B | 23.69 |
| Envista Holdings (NVST) | United States | $3.068B | 25.49 |
| GN Store Nord (GNNDY) | Denmark | $2.170B | 17.98 |
| QuidelOrtho (QDEL) | United States | $2.005B | 13.79 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 40.61 |
| AtriCure (ATRC) | United States | $1.683B | 0.00 |
| Acuren (TIC) | United States | $1.297B | 0.00 |
| Neogen (NEOG) | United States | $1.235B | 15.81 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| Green Thumb Industries (GTBIF) | United States | $1.143B | 25.71 |
| Kestra Medical Technologies (KMTS) | United States | $1.062B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 12.74 |
| BioLife Solutions (BLFS) | United States | $0.983B | 0.00 |
| InMode (INMD) | Israel | $0.907B | 9.14 |
| Evolus (EOLS) | United States | $0.643B | 0.00 |
| CeriBell (CBLL) | United States | $0.621B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.549B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.536B | 0.00 |
| Owens & Minor (OMI) | United States | $0.491B | 4.07 |
| Capricor Therapeutics (CAPR) | United States | $0.466B | 0.00 |
| Surmodics (SRDX) | United States | $0.421B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.410B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.61 |
| Aurora Cannabis (ACB) | Canada | $0.293B | 52.10 |
| Cresco Labs (CRLBF) | United States | $0.289B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.259B | 21.87 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.40 |
| Verano Holdings (VRNOF) | United States | $0.226B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.224B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.213B | 0.00 |
| Quanterix (QTRX) | United States | $0.204B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.197B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.45 |
| Brainsway (BWAY) | Israel | $0.193B | 51.10 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Omeros (OMER) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.48 |
| Organigram Global (OGI) | Canada | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.152B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.139B | 17.12 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| MacroGenics (MGNX) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Agape ATP (ATPC) | $0.080B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.061B | 0.00 |
| Zynex (ZYXI) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| United Health Products (UEEC) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.29 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.033B | 44.71 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |